Browse by author
Lookup NU author(s): Monica Hansrani, Klaus Overbeck, Dr Jonathan Smout, Professor Gerard Stansby
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Introduction: intravascular brachytherapy (IVBT) utilises the percutaneous insertion of a radioactive source to inhibit myointimal hyperplasia in arteries treated by balloon angioplasty or stenting. A systematic review was performed of trials of WET in patients with Peripheral Arterial Disease (PAD). Methods: search strategy - the reviewers searched Medline, Embase, the Cochrane Peripheral Vascular Diseases Group trials register, DARE, CCT and NHS EED for clinical studies and trials of adjuvant WET in PAD. Two reviewers assessed trial quality independently. Results: fourteen clinical trials were identified by the search, representing five clinical studies (all allocated D for not randomised) and one randomised controlled trial (allocated A). The randomised trial showed a benefit for WET compared with placebo (OR 0.35, 95% CI 0.24-0.53). In the non-randomised studies, 12 month cumulative patency rates ranged from 60-87%. There were few technical complications. In the only report involving WET and routine concurrent stent insertion acute thrombosis occurred in 7 (21%) of patients. Conclusion: early reports have confirmed the safety and technical feasibility of WET. However, follow-up is too short at present to assess the durability and long-term complications of this new therapeutic option. © 2002 Elsevier Science Ltd. All rights reserved.
Author(s): Overbeck K; Smout J; Stansby G; Hansrani M
Publication type: Review
Publication status: Published
Journal: European Journal of Vascular and Endovascular Surgery
Year: 2002
Volume: 24
Issue: 5
Pages: 377-382
ISSN (print): 1078-5884
ISSN (electronic): 1532-2165
URL: http://dx.doi.org/10.1053/ejvs.2002.1742
DOI: 10.1053/ejvs.2002.1742
PubMed id: 12435336
